Adynamic Bone Decreases Bone Toughness During Aging by Affecting Mineral and Matrix
- PMID: 26332924
- DOI: 10.1002/jbmr.2702
Adynamic Bone Decreases Bone Toughness During Aging by Affecting Mineral and Matrix
Abstract
Adynamic bone is the most frequent type of bone lesion in patients with chronic kidney disease; long-term use of antiresorptive therapy may also lead to the adynamic bone condition. The hallmark of adynamic bone is a loss of bone turnover, and a major clinical concern of adynamic bone is diminished bone quality and an increase in fracture risk. Our current study aims to investigate how bone quality changes with age in our previously established mouse model of adynamic bone. Young and old mice (4 months old and 16 months old, respectively) were used in this study. Col2.3Δtk (DTK) mice were treated with ganciclovir and pamidronate to create the adynamic bone condition. Bone quality was evaluated using established techniques including bone histomorphometry, microcomputed tomography, quantitative backscattered electron imaging, and biomechanical testing. Changes in mineral and matrix properties were examined by powder X-ray diffraction and Raman spectroscopy. Aging controls had a natural decline in bone formation and resorption with a corresponding deterioration in trabecular bone structure. Bone turnover was severely blunted at all ages in adynamic animals, which preserved trabecular bone loss normally associated with aging. However, the preservation of trabecular bone mass and structure in old adynamic mice did not rescue deterioration of bone mechanical properties. There was also a decrease in cortical bone toughness in old adynamic mice that was accompanied by a more mature collagen matrix and longer bone crystals. Little is known about the effects of metabolic bone disease on bone fracture resistance. We observed an age-related decrease in bone toughness that was worsened by the adynamic condition, and this decrease may be due to material level changes at the tissue level. Our mouse model may be useful in the investigation of the mechanisms involved in fractures occurring in elderly patients on antiresorptive therapy who have very low bone turnover.
Keywords: AGING; ANTIRESORPTIVES; BIOMECHANICS; BONE MATRIX; COLLAGEN; ORTHOPEDICS; THERAPEUTICS.
© 2015 American Society for Bone and Mineral Research.
Similar articles
-
Development, validation and characterization of a novel mouse model of Adynamic Bone Disease (ABD).Bone. 2014 Nov;68:57-66. doi: 10.1016/j.bone.2014.07.037. Epub 2014 Aug 8. Bone. 2014. PMID: 25111968
-
Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.J Bone Miner Res. 2005 Aug;20(8):1414-29. doi: 10.1359/JBMR.050315. Epub 2005 Mar 14. J Bone Miner Res. 2005. PMID: 16007339
-
Bone Marrow Stress Decreases Osteogenic Progenitors.Calcif Tissue Int. 2015 Nov;97(5):476-86. doi: 10.1007/s00223-015-0032-3. Epub 2015 Jul 29. Calcif Tissue Int. 2015. PMID: 26220824
-
Bone as a Structural Material.Adv Healthc Mater. 2015 Jun 24;4(9):1287-304. doi: 10.1002/adhm.201500070. Epub 2015 Apr 10. Adv Healthc Mater. 2015. PMID: 25865873 Review.
-
Osteoporosis and adynamic bone in chronic kidney disease.J Nephrol. 2013 Jan-Feb;26(1):73-80. doi: 10.5301/jn.5000212. J Nephrol. 2013. PMID: 23023723 Review.
Cited by
-
Traditional and Non-traditional Risk Factors for Osteoporosis in CKD.Calcif Tissue Int. 2021 Apr;108(4):496-511. doi: 10.1007/s00223-020-00786-0. Epub 2021 Feb 14. Calcif Tissue Int. 2021. PMID: 33586002 Review.
-
Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis.Front Physiol. 2023 Jun 5;14:1177829. doi: 10.3389/fphys.2023.1177829. eCollection 2023. Front Physiol. 2023. PMID: 37342799 Free PMC article. Review.
-
Bone Material Properties in Bone Diseases Affecting Children.Curr Osteoporos Rep. 2023 Dec;21(6):787-805. doi: 10.1007/s11914-023-00822-6. Epub 2023 Oct 28. Curr Osteoporos Rep. 2023. PMID: 37897675 Review.
-
Fluid shear stress-induced down-regulation of miR-146a-5p inhibits osteoblast apoptosis via targeting SMAD4.Physiol Res. 2022 Dec 16;71(6):835-848. doi: 10.33549/physiolres.934922. Epub 2022 Oct 13. Physiol Res. 2022. PMID: 36281726 Free PMC article.
-
Management of adynamic bone disease in chronic kidney disease: A brief review.J Clin Transl Endocrinol. 2016 Jul 25;5:32-35. doi: 10.1016/j.jcte.2016.07.002. eCollection 2016 Sep. J Clin Transl Endocrinol. 2016. PMID: 29067232 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical